Homocysteine: normal levels, B12 and folate link, and risks

Homocysteine is an amino acid your body makes as a byproduct of processing methionine, another amino acid that comes from protein in food. Under normal conditions it does not build up: vitamin B12, folate and vitamin B6 act as cofactors that recycle it back into methionine or convert it into cysteine. When that recycling slows down, homocysteine accumulates in the blood — and a homocysteine test measures exactly how much is circulating at that moment.

This article explains what a homocysteine result reflects, the reference band commonly printed on lab reports, what makes the number rise, and when a clinician actually orders the test. It does not cover the diagnosis, symptoms or treatment of vitamin B12 or folate deficiency — that is a separate subject, covered in our guide to vitamin B12 and folate. It also does not recommend any supplement dose: whether and how to correct a vitamin shortfall is a decision for a clinician, not a number on a page.

Homocysteine categories and what they can mean

Homocysteine is reported in micromoles per litre (µmol/L). Reference intervals vary slightly by laboratory and assay, so the range printed on your own report is the one that applies to your result. As a general reference, StatPearls (NCBI Bookshelf) describes a normal range of roughly 5 to 15 µmol/L, with hyperhomocysteinemia defined as a level above 15 µmol/L and graded further from there.

These bands describe where a result falls, not what to do about it. A single elevated value does not diagnose any disease, and a value inside the normal range does not exclude every relevant condition — the number is one input among several that a clinician weighs together.

Reading homocysteine alongside other markers, not alone

A raised homocysteine level rarely stands on its own in clinical reasoning. Because B12, folate and B6 all feed into the same pathway, a clinician who sees an elevated result often looks at vitamin B12 and folate levels directly, sometimes alongside methylmalonic acid, which behaves as a more specific marker of B12 status. Our guide to vitamin B12 and folate covers how those tests are read and what a true deficiency looks like; this article stops at how homocysteine fits into that broader picture.

Homocysteine is also considered alongside cardiovascular risk markers rather than as a stand-alone predictor. It sits in the same general territory as the tests described in our overview of heart health blood tests, which covers lipids and inflammatory markers used together to build a fuller risk picture. On its own, homocysteine adds limited independent value to that assessment — see the section below on what an elevated result does and does not prove.

Reduced kidney function is another common contributor: the kidneys help clear homocysteine, so a result should generally be interpreted alongside markers such as those explained in kidney function tests and creatinine. Thyroid status matters too — hypothyroidism is associated with higher homocysteine, and our TSH test guide covers how thyroid function is assessed.

What raises homocysteine, and what does not need a genetic test

The most common contributors to a raised result, drawn from clinical sources rather than any single cause, include:

• Low B12, folate or B6 status — the pathway that clears homocysteine depends on all three;
• Reduced kidney function — clearance of homocysteine falls as kidney function declines, which is why chronic kidney disease is a recognised correlate of higher levels;
• Hypothyroidism — an underactive thyroid is associated with elevated homocysteine;
• Certain medicines — for example, long-term acid-suppressing medication has been linked to reduced B12 absorption, which can indirectly raise homocysteine;
• Smoking;
• Age and sex — levels tend to rise with age, and men typically run higher than women, though the gap narrows after menopause;
• MTHFR gene variants — a common enzyme variant that reduces the efficiency of the same recycling pathway.

That last point deserves a direct note: a homocysteine test does not screen for MTHFR variants, and MTHFR genotyping is not part of a standard homocysteine work-up. If levels stay persistently high despite adequate vitamin status, a clinician decides whether looking for a genetic cause would actually change anything for that person — genetic testing is not a default next step just because homocysteine is elevated.

What an elevated result does — and does not — prove

This is the point worth being precise about. Elevated homocysteine is associated with a higher risk of cardiovascular and thromboembolic disease; people with consistently high levels do, on average, show more of these events in observational studies. That association is real and has been observed repeatedly.

What has not held up is the next logical-sounding step: that lowering homocysteine with B vitamins removes that risk across the board. A Cochrane systematic review of randomised trials on homocysteine-lowering interventions found no difference in myocardial infarction or death from any cause, and a small reduction in stroke (relative risk 0.90, 95% CI 0.82–0.99). As MedlinePlus puts it, even though high homocysteine can damage arteries, “studies have shown that in most cases lowering homocysteine levels doesn’t reduce the risk of heart attack or stroke” — the two sources agree once you read them together: any benefit is small, limited to stroke, and not the reliable effect on heart attack or overall survival that would justify treating homocysteine as a target in its own right.

This is a textbook case of association not equaling causation: homocysteine may be a marker that travels alongside cardiovascular risk without itself being the mechanism that, once corrected, removes that risk. The one setting where lowering homocysteine has clearly helped is homocystinuria, a rare inherited disorder with very high levels — a different situation from the moderate elevations most people ever see on a routine panel. For everyone else, an elevated result is information to bring to a clinician, not a target to correct on your own with supplements.

When clinicians order a homocysteine test

Homocysteine is not a routine screening test for the general population. In practice, it tends to come up in more specific situations, decided case by case:

• working up suspected vitamin B12 or folate deficiency, particularly when direct vitamin levels are borderline or symptoms suggest a deficiency that blood levels alone have not confirmed;
• investigating unexplained blood clots, since elevated homocysteine is recognised as an independent risk factor for thrombotic disease;
• evaluating a possible inherited disorder of homocysteine metabolism, most notably when homocystinuria is suspected based on history, family history or physical findings;
• selected situations where a clinician wants a functional read on B-vitamin status that goes beyond a direct vitamin level.

These are examples of clinical judgement rather than a checklist to self-apply. Whether the test is useful in a given situation, and what a result should lead to, is decided by the person ordering it.

Preparation and factors that distort the result

Fasting instructions differ between laboratories: Testing.com states no fasting is needed for a homocysteine draw, while MedlinePlus states you may be asked to fast for 8–12 hours beforehand. Follow the instruction on your referral or from your laboratory, and ask if it is unclear. What does affect the number is largely the same list of contributing factors described above: age, sex, smoking status, kidney function, and recent B-vitamin intake, including supplements. Because reference intervals vary between laboratories and assay methods, compare your result only with the range printed on your own report, and prefer the same laboratory for any comparison over time.

When to seek prompt medical attention

Homocysteine testing itself is not an emergency test, and a single elevated result is not a reason for urgent concern on its own. Seek prompt medical attention for the underlying situations that sometimes prompt the test in the first place: new or worsening numbness, tingling or weakness, unexplained swelling or pain in a limb that could suggest a blood clot, or neurological symptoms alongside a known or suspected vitamin B12 deficiency. These are reasons to contact a clinician promptly regardless of whether a homocysteine result is available yet.

If a result comes back markedly high — in the range a laboratory flags as significant rather than moderate — it is worth not delaying a follow-up visit with the clinician who ordered the test, to clarify the cause and next steps.

Tracking homocysteine and related markers with HealthLab

Homocysteine is often ordered alongside vitamin B12, folate and other markers, and comparing them meaningfully means keeping the same units and reference ranges in view across visits. HealthLab imports lab reports from PDF or a photo and recognises the biomarkers automatically, or you can enter results manually with an editable reference range and a free-text unit — manual entry is free and unlimited, while the free tier includes one AI import to try it and unlimited AI import is part of Pro. Trend charts show each biomarker’s direction over time, and you can export a PDF of your results and trends to bring to an appointment. Additional profiles for family members come with Pro. HealthLab can also draw on health data from Apple Health where it is present, alongside your lab results, in the same app.

If you want a general starting point for making sense of a biomarker panel, our labs directory lists the laboratories HealthLab can read reports from. HealthLab organises your results and helps you prepare for a conversation with a doctor — it does not diagnose a condition or tell you whether a level needs treatment.

Frequently asked questions